Expert Reviews in Molecular Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.5 | Q1 | 83.9% | 1.686 | Q1 | 93.5% |
| 2024 | 5.5 | Q1 | 82.2% | 1.500 | Q1 | 92.2% |
| 2023 | 4.5 | Q2 | 72.8% | 1.357 | Q1 | 91.4% |
| 2022 | 6.2 | Q1 | 82.4% | 1.060 | Q2 | 87.5% |
| 2021 | 7.6 | Q1 | 83.8% | 1.285 | Q1 | 91.0% |
| 2020 | — | — | 1.122 | Q2 | 87.7% | |
| 2019 | — | — | 2.140 | Q1 | 96.1% | |
| 2018 | — | — | 1.983 | Q1 | 94.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1462-3994
region
Western Europe
coverage
1997-2026
